Nivolumab vs Valsartan

## Nivolumab vs Valsartan: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Valsartan**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Valsartan**: Angiotensin II type 1 receptor blocker.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Valsartan — 6 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Valsartan — C24H29N5O3.

**Molecular Weight**: Nivolumab — N/A; Valsartan — 435.5190 g/mol.

**Type**: Nivolumab — Antibody; Valsartan — Small molecule.